Protara Therapeutics
TARA
TARA
48 hedge funds and large institutions have $156M invested in Protara Therapeutics in 2020 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 15 increasing their positions, 11 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
21.26% more ownership
Funds ownership: 67.81% → 89.06% (+21%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
48
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$10.8M | |
| 2 | +$10.2M | |
| 3 | +$7.57M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
+$7.57M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$7.54M |
Top Sellers
| 1 | -$551K | |
| 2 | -$215K | |
| 3 | -$168K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$29.7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$7.71K |